Artificial intelligence news.
Straight from the original announcements.

Jumptuit wins USPTO patent for AI environmental health risk alerts

November 10, 2026, 13:42Source: PR Newswire
Jumptuit wins USPTO patent for AI environmental health risk alerts
Image: PR Newswire

Jumptuit has secured a U.S. patent for an artificial intelligence system designed to forecast environmental exposure and generate early, individualized health risk alerts. The company says the invention could support research and decision-making across health, life and environmental sciences.

Key points
  • The USPTO granted Jumptuit Patent No. 12793535.
  • The patent covers AI systems for environmental exposure and early health risk alerts.
  • The system uses geolocation data and changing environmental, disease and toxin variables.
  • Jumptuit links the invention to exposomic and genomic research.
  • The announcement gives no product launch or availability details.

Patent covers predictive environmental exposure analysis

The U.S. Patent and Trademark Office awarded the patent to Donald Leka, Jumptuit's founder and CEO, according to a Nov. 10 announcement distributed by PR Newswire. The patent is titled “AI Systems and Methods for Environmental Exposure and Early Health Risk Alerts” and carries Patent No. 12793535.

Jumptuit says the invention uses artificial intelligence to analyze dynamic environmental, disease and toxin exposure variables derived from recent geolocation data. The system is intended to produce early individualized notifications, including assessments of risks created by combinations of variables.

Rather than relying on a fixed threshold based on generalized historical environmental data, the company describes each forecast as a dynamic, location-specific predictive model. It is designed to identify patterns in the trend, sequence and velocity of changing variables in relation to an individual's health profile.

Forecasts can look beyond conditions already present

According to Jumptuit, the AI-generated forecasts can evaluate future localized conditions that have not yet occurred at a user's location. The company's description centers on recognizing how environmental, disease and toxin variables develop and interact, rather than evaluating those factors in isolation.

The company also connects the patent to exposomic and genomic research. Jumptuit says that mapping environmental exposures in real time could help bridge the gap between static genetic predisposition and gene expression by showing how changing physical variables interact with epigenetics to trigger disease manifestation.

Donald Leka said the technology could support a shift from historical exposomic analysis to continuous predictive observation. “By dynamically mapping the velocity and interaction of environmental, disease, and toxin variables, Jumptuit empowers researchers, healthcare providers, and public health officials to move from reactive mitigation to proactive, life saving intervention before environmental threats fully materialize,” he said.

Jumptuit places patent within wider AI research portfolio

The granted patent expands on several earlier Jumptuit patents covering AI-assisted search, event and location-based search, and the correlation of multiple data points into a single data point. The announcement lists patents numbered 12561386, 12361080, 11977584, 11971933 and 11803602.

Jumptuit Group describes itself as an AI research and development company working in “Anticipatory Intelligence.” Its stated purpose is to observe the antecedent elements of phenomena and events, their movements and the forces among them, using heightened sensory and spatial intelligence to advance scientific discovery and research.

For researchers, healthcare providers and public health officials, the patent represents Jumptuit's claimed framework for moving from retrospective analysis toward earlier warnings based on changing local conditions. The company also says the invention could help individuals anticipate compound environmental risks and understand their relationship to unique medical, biological and lifestyle health profiles. The announcement does not provide details about a product launch or public availability.

Related news

i-Lumen Reports Dry AMD Signals in i-SIGHT Feasibility Study
ResearchNovember 10, 2026, 15:17

i-Lumen Reports Dry AMD Signals in i-SIGHT Feasibility Study

i-Lumen Scientific reported findings from a randomized, sham-controlled feasibility study of its investigational AMD System, identifying potential improvements in visual…

TriNetX Adds Human-Validated Facts Extracted From Clinical Notes
Products and toolsNovember 10, 2026, 14:27

TriNetX Adds Human-Validated Facts Extracted From Clinical Notes

TriNetX has launched NLP-extracted Facts from Clinical Notes, a capability that gives researchers confidence-scored data points from clinical notes and links them to…

DentScribe Reports 100% Accuracy Across Eight Perio Charting Levels
Products and toolsNovember 10, 2026, 06:29

DentScribe Reports 100% Accuracy Across Eight Perio Charting Levels

DentScribe has launched its AI Periodontal Charting Benchmark 1.0 and reported that DentScribe 2.165.0 passed all 68 tests across eight levels. The company said the…